Autopsy report · NCT03251872

Olaparib for PAH: a Pilot Study

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“OPTION pilot trial merged with the new NCT03782818 - OPTION multicenter trial”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 2 months before it started.
Ran for about 1 year 1 month before it stopped.
6 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Early Phase 1
Sponsor: Laval University
Sponsor type: University, hospital or other
Conditions: Pulmonary Arterial Hypertension
Interventions: Olaparib
Participants: 6
Sites: 1
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.